Skip to main content
Top

Open Access 06-06-2025 | Pituitary Adenoma | Case Report

Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature

Authors: Miguel A. Del Toro-Colín, Martha Tena-Suck, Alberto Santiago-Balmaseda, Citlalteptl Salinas-Lara, Germán Velázquez-Garcia, Maria de Lourdes Aguilar-Gómez, Elsa Yazmín León-Marroquín, Carlos Sánchez-Garibay, Alma Ortíz-Plata, Roger Carrillo-Meza, Noemi Gelista-Herrera, Lesly Hernández-Roque, Luis O. Soto-Rojas

Published in: Brain Tumor Pathology

Login to get access

Abstract

The coexistence of three lesions in the sellar region is exceedingly rare. Only two cases with three histopathologically distinct lesions have been reported. However, here, we present a unique case of a 54-year-old female with pituitary adenoma (PA), xanthogranulomatous hypophysitis (XGH), and a Rathke cleft cyst (RCC). Clinically, the patient manifested symptoms of mass compression, such as moderate-intensity headaches and progressive visual acuity decrease. Relevant endocrinological evaluation revealed elevated free thyroxine levels without clinical manifestations. MRI revealed a suprasellar mass compatible with a macroadenoma. The patient underwent transsphenoidal endoscopic resection, resulting in a non-functional macroadenoma with associated XGH due to the rupture of RCC. Furthermore, in this article, we analyze the possible mechanisms involved in the pathogenesis of these lesions, emphasizing the type of spectrum to which they belong and the manifestations present.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature
Authors
Miguel A. Del Toro-Colín
Martha Tena-Suck
Alberto Santiago-Balmaseda
Citlalteptl Salinas-Lara
Germán Velázquez-Garcia
Maria de Lourdes Aguilar-Gómez
Elsa Yazmín León-Marroquín
Carlos Sánchez-Garibay
Alma Ortíz-Plata
Roger Carrillo-Meza
Noemi Gelista-Herrera
Lesly Hernández-Roque
Luis O. Soto-Rojas
Publication date
06-06-2025
Publisher
Springer Nature Singapore
Published in
Brain Tumor Pathology
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-025-00504-4

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest